BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14604563)

  • 1. The link between public and private insurance and HIV-related mortality.
    Bhattacharya J; Goldman D; Sood N
    J Health Econ; 2003 Nov; 22(6):1105-22. PubMed ID: 14604563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insurance status of HIV-infected adults in the post-HAART era: evidence from the United States.
    Goldman DP; Leibowitz AA; Joyce GF; Fleishman JA; Bozzette SA; Duan N; Shapiro MF
    Appl Health Econ Health Policy; 2003; 2(2):85-90. PubMed ID: 14619279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain and the use of outpatient services among persons with HIV: results from a nationally representative survey.
    Dobalian A; Tsao JC; Duncan RP
    Med Care; 2004 Feb; 42(2):129-38. PubMed ID: 14734950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA.
    Schneider G; Juday T; Wentworth C; Lanes S; Hebden T; Seekins D
    AIDS Care; 2013; 25(11):1470-6. PubMed ID: 23517139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment variation by insurance status for breast cancer patients.
    Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
    Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Private insurance and the utilization of chemical dependency treatment.
    Schmidt LA; Weisner CM
    J Subst Abuse Treat; 2005 Jan; 28(1):67-76. PubMed ID: 15723734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009.
    Ludema C; Cole SR; Eron JJ; Edmonds A; Holmes GM; Anastos K; Cocohoba J; Cohen M; Cooper HL; Golub ET; Kassaye S; Konkle-Parker D; Metsch L; Milam J; Wilson TE; Adimora AA
    J Acquir Immune Defic Syndr; 2016 Nov; 73(3):307-312. PubMed ID: 27763995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insured and non-insured depressed outpatients: how do they compare?
    Lesser IM; Leuchter AF; Trivedi MH; Davis LL; Wisniewski SR; Balasubramani GK; Fava M; Rush AJ
    Ann Clin Psychiatry; 2007; 19(2):73-82. PubMed ID: 17612846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitions in insurance and employment among people with HIV infection.
    Fleishman JA
    Inquiry; 1998; 35(1):36-48. PubMed ID: 9597016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insurance coverage and access to HIV testing and treatment: considerations for individuals at risk for infection and for those with undiagnosed infection.
    Kates J; Levi J
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S255-60. PubMed ID: 18190296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of ancillary services on primary care use and outcomes for HIV/AIDS patients with public insurance coverage.
    Conover CJ; Whetten-Goldstein K
    AIDS Care; 2002 Aug; 14 Suppl 1():S59-71. PubMed ID: 12204142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insurance status and access to primary health care:disparate outcomes for potentially preventable hospitalization.
    Laditka JN; Laditka SB
    J Health Soc Policy; 2004; 19(2):81-100. PubMed ID: 15774350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health insurance and health at age 65: implications for medical care spending on new Medicare beneficiaries.
    Hadley J; Waidmann T
    Health Serv Res; 2006 Apr; 41(2):429-51. PubMed ID: 16584457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of partial public insurance programs and residual private insurance markets: evidence from the US Medicare program.
    Finkelstein A
    J Health Econ; 2004 Jan; 23(1):1-24. PubMed ID: 15154686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of health insurance coverage in women's access to prescription medicines.
    Ranji UR; Wyn R; Salganicoff A; Yu H
    Womens Health Issues; 2007; 17(6):360-6. PubMed ID: 18042485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's health insurance coverage 1980-2005.
    Glied S; Jack K; Rachlin J
    Womens Health Issues; 2008; 18(1):7-16. PubMed ID: 18215762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insurance status and the use of guideline therapy in the treatment of selected cancers.
    Harlan LC; Greene AL; Clegg LX; Mooney M; Stevens JL; Brown ML
    J Clin Oncol; 2005 Dec; 23(36):9079-88. PubMed ID: 16301598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased rates of morbidity, mortality, and charges for hospitalized children with public or no health insurance as compared with children with private insurance in Colorado and the United States.
    Todd J; Armon C; Griggs A; Poole S; Berman S
    Pediatrics; 2006 Aug; 118(2):577-85. PubMed ID: 16882810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.